-
Published 5/25/2025
Koura KG, Soe AN, Dlodlo RA, Lin Y, Sinha P, Badoum G, Dogo MF, Horsburgh CR, Harries AD. Impact of US Government funding cessation on TB care and prevention: a multicountry survey in Africa. Int J Tuberc Lung Dis. 2025 May 25; 29(5):239-241. PMID: 40281676.
-
Published 5/8/2025
Hsieh YL, Horsburgh CR, Cohen T, Miller JW, Salomon JA, Menzies NA. Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants. PLoS Med. 2025 May 08; 22(5):e1004603. PMID: 40338978.
-
Published 4/10/2025
Swartwood NA, Haddad MB, Marks SM, Beeler Asay GR, Horsburgh CR, Cohen T, Menzies NA. Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States. Value Health. 2025 Apr 10. PMID: 40220866.
-
Published 3/27/2025
Niemand N, Rooney JA, Malatesta S, Rawoot N, Bouton TC, Ragan EJ, Carney T, White LF, Farhat M, Horsburgh CR, Myers B, Warren RM, Jacobson KR. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. medRxiv. 2025 Mar 27. PMID: 40196277.
-
Published 3/13/2025
Phillips PP, Peloquin CA, Sterling TR, Kaur P, Diacon AH, Gotuzzo E, Benator D, Warren RM, Sikes D, Lecca L, Gandhi NR, Streicher EM, Dianis N, Eisenach K, Mitnick CD, Horsburgh CR. Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 Trial. Am J Respir Crit Care Med. 2025 Mar 13. PMID: 40080768.